In the second installment of a two-part interview, George Rafferty, who has announced his retirement after heading AmerisourceBergen’s Corporate Partnerships Group for the past five years, and his successor, Claire Biermaas, talk about the leadership transition and the unique culture that enables the drug wholesaler to stay in sync with the evolving needs of its largest customers.
Video Forum: George Rafferty and Claire Biermaas, AmerisourceBergen
In the second installment of a two-part interview, George Rafferty, who has announced his retirement after heading AmerisourceBergen’s Corporate Partnerships Group for the past five years, and his successor, Claire Biermaas, talk about the leadership transition and the unique culture that enables th
Latest
Nine of the largest pharma companies ink deals with Trump to lower drug prices
The agreements reduce prices on drugs that treat numerous costly and chronic conditions.
Merck and U.S. government partner to expand access to medicines and reduce costs for Americans
The company has committed more than $70 billion in U.S. investments to boost domestic production and innovation.
Google Trends looks at 2026 wellness shifts
Google Trends analysis revealed that new types of health-related searches emerged in the second half of 2025 and will continue into next year.
CRN appoints 2026 board leaders amid supplement regulation pressure
The Council for Responsible Nutrition announced its 2026 Board of Directors as it gears up for increased regulation and legislation.